MY169330A - Method for inhibition of deubiquitinating activity - Google Patents
Method for inhibition of deubiquitinating activityInfo
- Publication number
- MY169330A MY169330A MYPI2014001125A MYPI2014001125A MY169330A MY 169330 A MY169330 A MY 169330A MY PI2014001125 A MYPI2014001125 A MY PI2014001125A MY PI2014001125 A MYPI2014001125 A MY PI2014001125A MY 169330 A MY169330 A MY 169330A
- Authority
- MY
- Malaysia
- Prior art keywords
- inhibition
- compound
- deubiquitinating activity
- treatment
- deubiquitinating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1100776 | 2011-10-19 | ||
| SE1200303 | 2012-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY169330A true MY169330A (en) | 2019-03-21 |
Family
ID=48141165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2014001125A MY169330A (en) | 2011-10-19 | 2012-10-15 | Method for inhibition of deubiquitinating activity |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9221761B2 (OSRAM) |
| EP (1) | EP2780326B1 (OSRAM) |
| JP (1) | JP6165748B2 (OSRAM) |
| KR (1) | KR102022575B1 (OSRAM) |
| CN (1) | CN104271557B (OSRAM) |
| AU (1) | AU2012326682B2 (OSRAM) |
| BR (1) | BR112014009365B1 (OSRAM) |
| CA (1) | CA2852518C (OSRAM) |
| CL (1) | CL2014000998A1 (OSRAM) |
| DK (1) | DK2780326T3 (OSRAM) |
| EA (1) | EA026409B1 (OSRAM) |
| ES (1) | ES2713484T3 (OSRAM) |
| HU (1) | HUE041816T2 (OSRAM) |
| IL (1) | IL232118A (OSRAM) |
| MX (1) | MX345467B (OSRAM) |
| MY (1) | MY169330A (OSRAM) |
| PL (1) | PL2780326T3 (OSRAM) |
| PT (1) | PT2780326T (OSRAM) |
| SG (1) | SG11201401608PA (OSRAM) |
| WO (1) | WO2013058691A1 (OSRAM) |
| ZA (1) | ZA201403302B (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102022575B1 (ko) * | 2011-10-19 | 2019-09-18 | 비보룩스 아베 | 탈유비퀴틴화 활성의 저해 방법 |
| JP2016504365A (ja) | 2012-12-28 | 2016-02-12 | アメリカ合衆国 | Ｕｓｐ１／ｕａｆ１デユビキチナーゼ複合体阻害剤及びその使用 |
| WO2016004221A1 (en) * | 2014-07-01 | 2016-01-07 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying and treating mammals resistant to proteasome inhibitor treatments |
| GB201416754D0 (en) * | 2014-09-23 | 2014-11-05 | Mission Therapeutics Ltd | Novel compounds |
| MD3277677T2 (ro) * | 2015-03-30 | 2021-07-31 | Mission Therapeutics Ltd | Compuși de 1-ciano-pirolidină utilizați ca inhibitori de USP30 |
| CN106146542A (zh) * | 2015-04-23 | 2016-11-23 | 北京大学 | 姜黄素硼酸衍生物,其制备方法和应用 |
| GB201522768D0 (en) * | 2015-12-23 | 2016-02-03 | Mission Therapeutics Ltd | Novel compounds |
| US10416163B2 (en) * | 2016-02-26 | 2019-09-17 | Regents Of The University Of Minnesota | Method and treatment of recurring endometrial cancer with an inhibitor of USP14 |
| JP2020506230A (ja) * | 2017-01-30 | 2020-02-27 | アップ セラピューティクス インコーポレイテッド | がん、糖尿病および神経障害の処置のための新規スピロおよび環式ビス−ベンジリジンプロテアソーム阻害剤 |
| CN111956804B (zh) * | 2020-07-21 | 2022-01-07 | 广州医科大学 | Otub1的抑制剂的新应用 |
| CN114959036A (zh) * | 2022-06-07 | 2022-08-30 | 北京大学 | Rpn11标记物在检测骨髓瘤及其患病风险、预后分析及治疗药物中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU779230C (en) * | 1999-12-03 | 2006-05-25 | Emory University | Curcumin analogues for treating cancer |
| CA2478522A1 (en) * | 2002-03-08 | 2003-09-18 | Emory University | Novel curcuminoid-factor viia constructs as suppressors of tumor growth and angiogenesis |
| US20070010488A1 (en) * | 2005-04-13 | 2007-01-11 | Khairia Youssef | Compounds for modulating cell proliferation |
| EP1749822B1 (en) * | 2005-08-05 | 2008-10-15 | Hybrigenics S.A. | Novel cysteine protease inhibitors and their therapeutic applications |
| US7582655B2 (en) * | 2005-11-22 | 2009-09-01 | University Of Saskatchewan | Antineoplastic compounds |
| WO2011005790A1 (en) * | 2009-07-06 | 2011-01-13 | The Ohio State University Research Foundation | Compositions and methods for inhibition of cancers |
| KR102022575B1 (ko) * | 2011-10-19 | 2019-09-18 | 비보룩스 아베 | 탈유비퀴틴화 활성의 저해 방법 |
-
2012
- 2012-10-15 KR KR1020147012947A patent/KR102022575B1/ko not_active Expired - Fee Related
- 2012-10-15 BR BR112014009365-2A patent/BR112014009365B1/pt not_active IP Right Cessation
- 2012-10-15 WO PCT/SE2012/000158 patent/WO2013058691A1/en not_active Ceased
- 2012-10-15 PL PL12841677T patent/PL2780326T3/pl unknown
- 2012-10-15 CN CN201280062713.XA patent/CN104271557B/zh not_active Expired - Fee Related
- 2012-10-15 CA CA2852518A patent/CA2852518C/en active Active
- 2012-10-15 HU HUE12841677A patent/HUE041816T2/hu unknown
- 2012-10-15 PT PT12841677T patent/PT2780326T/pt unknown
- 2012-10-15 DK DK12841677.3T patent/DK2780326T3/en active
- 2012-10-15 AU AU2012326682A patent/AU2012326682B2/en not_active Ceased
- 2012-10-15 EP EP12841677.3A patent/EP2780326B1/en active Active
- 2012-10-15 JP JP2014537023A patent/JP6165748B2/ja not_active Expired - Fee Related
- 2012-10-15 MX MX2014004646A patent/MX345467B/es active IP Right Grant
- 2012-10-15 MY MYPI2014001125A patent/MY169330A/en unknown
- 2012-10-15 EA EA201490800A patent/EA026409B1/ru not_active IP Right Cessation
- 2012-10-15 SG SG11201401608PA patent/SG11201401608PA/en unknown
- 2012-10-15 ES ES12841677T patent/ES2713484T3/es active Active
-
2014
- 2014-04-13 IL IL232118A patent/IL232118A/en active IP Right Grant
- 2014-04-17 CL CL2014000998A patent/CL2014000998A1/es unknown
- 2014-04-18 US US14/256,280 patent/US9221761B2/en not_active Expired - Fee Related
- 2014-05-08 ZA ZA2014/03302A patent/ZA201403302B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY169330A (en) | Method for inhibition of deubiquitinating activity | |
| NZ709635A (en) | Bcl-2bcl-xl inhibitors and therapeutic methods using the same | |
| UA111386C2 (uk) | Піридопіразини, які мають протиракову активність через інгібування fgfr-кіназ | |
| MX336214B (es) | Derivados de pirrolotriazinona como inhibidores de pi3k. | |
| MX382562B (es) | Derivados pirrolidina espiro-condensados como inhibidores de enzimas desubiquitinantes (dub). | |
| MX363243B (es) | Composiciones para tratar cáncer y usos de dichas composiciones. | |
| MX2014003376A (es) | Derivados de acido benzoico como inhibidores eif4e. | |
| WO2015095819A3 (en) | Cancer treatment using combinations of erk and raf inhibitors | |
| MY183661A (en) | Treatment of cancer with tor kinase inhibitors | |
| PH12014501542A1 (en) | Substituted pyrrolidine -2- carboxamides | |
| MX2013012979A (es) | Piridina y derivados de pirazina. | |
| MD20160016A2 (ro) | Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care le conţin | |
| MX2013012588A (es) | Inhibidores de cinasa. | |
| PH12014501639A1 (en) | Pharmaceutical compositions and methods | |
| MX362939B (es) | Derivados de (aza-)isoquinolinona. | |
| PH12015501088A1 (en) | Dimeric compounds | |
| MX350112B (es) | Derivados de furo[3,2-b]- y tieno[3,2-b]piridina como inhibidores de tbk1 e ikk. | |
| MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
| MX2013012977A (es) | Derivados de tiazol. | |
| GEP20115342B (en) | New diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PH12014500990A1 (en) | Methods for treating gout flares | |
| WO2013112699A3 (en) | Proteasome activity enhancing compounds | |
| MX2016016388A (es) | Uso de compuestos de tienotriazolodiazepina para el tratamiento de cancer de pulmon de celula no pequeña y/o cancer de pulmon de celula pequeña. | |
| MX2016001536A (es) | Derivados de urea de piperidinas. | |
| PH12015500399A1 (en) | Azaindolines |